VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 105 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 12.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,163 | -18.4% | 4,900 | -94.6% | 0.01% | -16.7% |
| Q1 2023 | $11,223 | +55.7% | 90,000 | +28.6% | 0.01% | +50.0% |
| Q4 2022 | $7,210 | -19.9% | 70,000 | +16.7% | 0.00% | -33.3% |
| Q3 2022 | $9,000 | -66.7% | 60,000 | +94.4% | 0.01% | -70.0% |
| Q2 2022 | $27,000 | -43.8% | 30,859 | -5.0% | 0.02% | +25.0% |
| Q1 2022 | $48,000 | +140.0% | 32,500 | +225.0% | 0.02% | +33.3% |
| Q4 2021 | $20,000 | +300.0% | 10,000 | +400.0% | 0.01% | +300.0% |
| Q3 2021 | $5,000 | 0.0% | 2,000 | +17.6% | 0.00% | 0.0% |
| Q2 2021 | $5,000 | – | 1,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Performa Ltd (US), LLC | 4,900 | $9,163 | 0.01% |